Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia Grants Stem Cell Line To Disgraced S. Korea Researcher

This article was originally published in PharmAsia News

Executive Summary

South Korea's disgraced stem cell scientist has been granted a patent in Australia for a line of cloned human embryo stem cells for research. Hwang Woo-suk was fired by Seoul National University after it was discovered he falsified parts of his groundbreaking research that gained international attention. He is still on trial in South Korea on charges of fraud and violating bioethics laws. The new stem cell line now protected in Australia is the same NT-1 line he worked on, but which was discovered to have been grown from unfertilized eggs, contrary to his claim to have produced the first cloned embryo. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel